Overview of the European and North American studies on HPV testing in primary cervical cancer screening
- PMID: 16586444
- DOI: 10.1002/ijc.21955
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
Abstract
Several studies suggest that HPV testing is more sensitive than cytology in primary cervical screening. These studies had different designs and were reported in different ways. Individual patient data were collected for all European and North American studies in which cytology was routinely performed and HPV testing was included as an additional parallel test. More than 60,000 women were included. The sensitivity and specificity of HPV testing were compared with routine cytology, both overall and for ages <35, 35-49 and 50+. The age-specific prevalence of high risk HPV (hr-HPV) was also analysed. HPV testing was substantially more sensitive in detecting CIN2+ than cytology (96.1% vs. 53.0%) but less specific (90.7% vs. 96.3%). The sensitivity of HPV testing was similar in all studies carried out in different areas of Europe and North America, whereas the sensitivity of cytology was highly variable. HPV sensitivity was uniformly high at all ages, whereas the sensitivity of cytology was substantially better in women over the age of 50 than in younger women (79.3% vs. 59.6%). The specificity of both tests increased with age. Positivity rates for HPV testing in women without high-grade CIN were region dependent. These results support the use of HPV testing as the sole primary screening test, with cytology reserved for women who test HPV positive. Large demonstration projects are needed to fully evaluate this strategy.
Copyright 2006 Wiley-Liss, Inc.
Similar articles
-
Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.Lancet. 2011 Nov 26;378(9806):1868-73. doi: 10.1016/S0140-6736(11)61522-5. Epub 2011 Nov 1. Lancet. 2011. PMID: 22051739 Clinical Trial.
-
Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.BJOG. 2004 Aug;111(8):842-8. doi: 10.1111/j.1471-0528.2004.00210.x. BJOG. 2004. PMID: 15270934
-
Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.Vaccine. 2012 Nov 20;30 Suppl 5:F88-99. doi: 10.1016/j.vaccine.2012.06.095. Vaccine. 2012. PMID: 23199969 Review.
-
Human papillomavirus testing for primary cervical cancer screening.Expert Rev Mol Diagn. 2008 Sep;8(5):599-605. doi: 10.1586/14737159.8.5.599. Expert Rev Mol Diagn. 2008. PMID: 18785808 Review.
-
Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: an international cohort study of cervical pathology in HIV-1 positive women.Int J Cancer. 2007 Dec 1;121(11):2484-91. doi: 10.1002/ijc.22947. Int J Cancer. 2007. PMID: 17683070
Cited by
-
Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination.Nat Rev Clin Oncol. 2024 Jul;21(7):522-538. doi: 10.1038/s41571-024-00904-z. Epub 2024 May 17. Nat Rev Clin Oncol. 2024. PMID: 38760499 Review.
-
Predictable changes in the accuracy of human papillomavirus tests after vaccination: review with implications for performance monitoring in cervical screening.Br J Cancer. 2024 May;130(11):1733-1743. doi: 10.1038/s41416-024-02681-z. Epub 2024 Apr 13. Br J Cancer. 2024. PMID: 38615108 Free PMC article. Review.
-
Clinical Validation of the Vitro HPV Screening Assay for Its Use in Primary Cervical Cancer Screening.Cancers (Basel). 2024 Mar 28;16(7):1322. doi: 10.3390/cancers16071322. Cancers (Basel). 2024. PMID: 38611001 Free PMC article.
-
CRISPR-Based Multiplex Detection of Human Papillomaviruses for One-Pot Point-of-Care Diagnostics.ACS Synth Biol. 2024 Mar 15;13(3):837-850. doi: 10.1021/acssynbio.3c00655. Epub 2024 Feb 13. ACS Synth Biol. 2024. PMID: 38349963 Free PMC article.
-
PCDHGB7 hypermethylation-based Cervical cancer Methylation (CerMe) detection for the triage of high-risk human papillomavirus-positive women: a prospective cohort study.BMC Med. 2024 Feb 5;22(1):55. doi: 10.1186/s12916-024-03267-5. BMC Med. 2024. PMID: 38317152 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical